May 27 (Reuters) - Eli Lilly ( LLY ) will acquire
privately held SiteOne Therapeutics, the companies said on
Tuesday, giving the drugmaker access to an experimental
non-opioid pain drug.
(Reporting by Sriparna Roy in Bengaluru; Editing by Devika
Syamnath)